• Profile
Close

DNA methylation-mediated silencing of miR-204 is a potential prognostic marker for papillary thyroid carcinoma

Cancer Management and Research Feb 18, 2019

Xia F, et al. - Researchers performed bioinformatics analyses to explore the molecular mechanisms underlying papillary thyroid carcinoma (PTC) tumorigenesis and progression, focusing on underlying molecular mechanisms of miR-204 involved in PTC. They performed microRNA (miRNA) microarray analysis to reveal miRNA expression patterns of PTC. For validation, The Cancer Genome Atlas (TCGA) data were used. They identified 181 miRNAs (89 downregulated and 92 upregulated miRNAs) which were differentially expressed between PTC and normal tissues. Based on the findings, a potential diagnostic biomarker of PTC could be promoter DNA methylation-silenced miR-204. By involvement in many tumor-related pathways, miR-204 downregulation could play an important role in PTC. There is a need for further validating novel target genes and putative mechanisms of miR-204 in PTC.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay